Dr Lisa Iversen
AFHEA; PhD; MSc Epidemiology: Principles & Practice; DLSHTM; BSc (Hons)
- AFHEA2021 - Advance HE
- PhD General Practice & Primary Care2006 - University of Aberdeen
- MSc Epidemiology: Principles & Practice2004 - London School of Hygiene & Tropical Medicine, University of London
- DLSHTM (Diploma of the London School of Hygiene & Tropical Medicine)2004 - University of London
- BSc (Hons) Health Sciences1998 - University of Aberdeen
Memberships and Affiliations
- Internal Memberships
2016 - present Athena SWAN self-assessment team member for the Institute of Applied Health Sciences.
2016 - 2019 Athena SWAN co-champion for the Institute of Applied Health Sciences.
2016 - 2019 Member University Committee for Athena SWAN leads with the Principal.
2010 - 2018 Member Institute of Applied Health Sciences Research Governance & Quality Assurance Committee.
2008 - 2009 Member, Academic Expectations Working Group, School of Medicine & Dentistry & Medical Sciences.
- External Memberships
2013 - present Scottish Crucible Alumni.
2005 - 2016 Member, SAPC Primary Care Epidemiology Special Interest Group.
2003 - 2005 Member, Platform Project Rural Health Interest Group.
2001 - 2016 Member, Society for Academic Primary Care.
2001 - 2004 Member, The Institute for Rural Health.
1999 - 2011 Lay member, NHS Grampian Pharmacy Practices Committee.
1997 - 1999 Member, Grampian Local Health Council.
Prizes and Awards
2013 Scottish Crucible professional and personal leadership and development programme.
2001 - 2004 Chief Scientist Office Research Training Fellow.
My research mainly examines the influences on women's health particularly in midlife and beyond, often using routinely collected data and includes:
- The Royal College of General Practioners' Oral Contraception Study (a prospective cohort study established in 1968).
- The influence of contemporary hormonal contraception on the risk of cancers in women of reproductive age.
- Uptake of cancer screening.
- Menopausal symptoms.
- Sequelae of common surgeries, commonly prescribed medications, pre-eclampsia and midlife lifestyle.
Applied Health Sciences
Professor Lidegaard, Department of Obstetrics & Gynaecology, Rigshospitalet, University of Copenhagen.
Dr Gerald Lip, Clinical Director North East Scotland Breast Screening Programme & Consultant Radiologist NHS Grampian.
Teach various aspects of epidemiology and develop teaching materials to contribute to a number of postgraduate courses.
Page 1 of 6 Results 1 to 10 of 58
Exploring the influence of rural residence on uptake of organized cancer screening: a systematic review of international literatureCancer Epidemiology, vol. 74, 101995Contributions to Journals: Articles
Contemporary hormonal contraception and cervical cancer in women of reproductive ageInternational Journal of Cancer, vol. 149, no. 4, pp. 769-777Contributions to Journals: Articles
Reproductive pattern of parous women and the risk of cancer in later lifeCancers, vol. 13, no. 15, 3731Contributions to Journals: Articles
Is place or person more important in determining higher rural cancer mortality?: A datalinkage study to compare individual versus area-based measures of deprivationInternational Journal of Population Data Science, vol. 6, no. 1, 11Contributions to Journals: Articles
Contraception Cancer Risks and BenefitsFemale and Male Contraception. Springer, pp. 161-194, 34 pagesChapters in Books, Reports and Conference Proceedings: Chapters
Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: a retrospective cohort study of Danish womenContraception, vol. 102, no. 3, pp. 152-158Contributions to Journals: Articles
Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studiesBritish Journal of Cancer, vol. 123, pp. 307-315Contributions to Journals: Articles
Clinical features in primary care electronic records before diagnosis of Ankylosing Spondylitis: a nested case-control studyBMC Family Practice, vol. 21, 78Contributions to Journals: Articles
Statin use and risk of liver cancer: Evidence from two population-based studiesInternational Journal of Cancer, vol. 146, no. 5, pp. 1250-1260Contributions to Journals: Articles
The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk: A nested case‐control studyPharmacoepidemiology and Drug Safety, vol. 29, no. 1, pp. 48-56Contributions to Journals: Articles